You rarely get the chance to change an entire industry. But that's the position we find ourselves in. Join us, and you'll help scale cures to patients that need them sooner.
We've developed fully-automated cell manufacturing sites, powered by custom robotics - to scale treatments to millions of patients. Last year, patients were cured of diseases like Parkinson's and vision loss using stem-cell derived cells - but today these Regenerative Medicines are produced by hand, meaning they're too expensive and hard to scale.
With our automated manufacturing sites, these therapies can now be scaled globally at low cost. We've announced partnerships across multiple therapies so far ranging from Parkinson's, to hearing loss, to bone repair - and raised $35m to expand into the market faster, and accelerate our development! Within the next 12 months, neurons grown on our machines will be going into Parkinson's patient brains.
We've assembled a world-class team to take on this challenge, with ex-Dyson engineers and Nature-published scientists working hand-in-hand. Mytos is backed by Y Combinator, the most successful startup program in the world which produced companies such as AirBnb, Dropbox, and Ginkgo Bioworks.
Building a supply chain that gives Mytos the ability to deliver accessible cures to patients. This includes lower COGS, shorter lead times, resilient supply, and a supplier base ready for GMP regulatory scrutiny.
Working across two tech stacks: electromechanical automation systems with custom robotics, and sterile fluidic plastic consumables made to GMP standards. You'll own the supply chain for both.
A foundational, hands-on role setting strategy: who we buy from, what we pay, and how we plan for scale. This can span from negotiating a volume deal with a contract manufacturer to keeping on top of incoming orders to catch manufacturer delays early.
You'll report to our Hardware Lead and work closely with manufacturing, biology, engineering, operations, quality and finance.
We're building a team that enjoys moving fast, strives for continuous improvement through learning from mistakes, and is passionate about work that contributes to solving real world problems.
Join us if you want a fast-paced environment, where you're empowered to make decisions and do the best work of your career.

Mytos automates production of stem cell-derived therapies - enabling them to scale to millions of patients at low cost. Our custom iDEM robotics platform powers our automated CDMO.
Our announced partnerships include neurons for treating Parkinson's, bone for bone repair, corneal cells for blindness, and auditory neurons for hearing loss (and we have more to announce). Cells produced on our iDEM platform will be going into patients by 2027.
Mytos has raised over $24m from leading investors, including YCombinator, Buckley Ventures and IQ Capital - as well as founders and execs from companies like Kite, Sana, Dropbox, and Revolut. Our team is made up of brilliant engineers from companies like Dyson and Autodesk - working hand-in-hand with Nature-published scientists.
We're hiring now - visit our website to see open positions